Home  /  Resource Library  /  Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low Tumour Burden Follicular Lymphoma: Final Results of a Randomised Phase 3 Study

Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low Tumour Burden Follicular Lymphoma: Final Results of a Randomised Phase 3 Study

Results of a study examining biosimilar Truxima for treatment of follicular lymphoma.